Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 29 | 2024 | 8599 | 2.380 |
Why?
|
Astrocytes | 6 | 2024 | 1346 | 1.210 |
Why?
|
Metformin | 3 | 2024 | 906 | 0.770 |
Why?
|
Memory Disorders | 2 | 2019 | 1198 | 0.760 |
Why?
|
Dementia | 4 | 2023 | 2686 | 0.760 |
Why?
|
Microglia | 7 | 2024 | 1361 | 0.740 |
Why?
|
Apolipoproteins E | 4 | 2021 | 1444 | 0.730 |
Why?
|
Receptors, CXCR | 1 | 2019 | 52 | 0.660 |
Why?
|
Genomics | 5 | 2024 | 5821 | 0.660 |
Why?
|
Nerve Degeneration | 2 | 2020 | 748 | 0.610 |
Why?
|
Brain | 21 | 2024 | 27112 | 0.580 |
Why?
|
Macrophage-1 Antigen | 1 | 2018 | 285 | 0.570 |
Why?
|
Nootropic Agents | 1 | 2018 | 157 | 0.560 |
Why?
|
Plaque, Amyloid | 6 | 2024 | 760 | 0.530 |
Why?
|
Neurodegenerative Diseases | 2 | 2020 | 1087 | 0.470 |
Why?
|
Haplotypes | 1 | 2020 | 2713 | 0.440 |
Why?
|
Amyloid beta-Peptides | 8 | 2024 | 3839 | 0.400 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1886 | 0.390 |
Why?
|
Hypoglycemic Agents | 2 | 2024 | 3085 | 0.390 |
Why?
|
Models, Statistical | 2 | 2023 | 5079 | 0.380 |
Why?
|
Neurofibrillary Tangles | 3 | 2023 | 457 | 0.370 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2223 | 0.360 |
Why?
|
Disease Progression | 2 | 2024 | 13506 | 0.350 |
Why?
|
Neurons | 5 | 2020 | 9463 | 0.350 |
Why?
|
Internet | 5 | 2024 | 3092 | 0.340 |
Why?
|
Energy Metabolism | 1 | 2020 | 2882 | 0.330 |
Why?
|
Frontotemporal Dementia | 2 | 2024 | 247 | 0.330 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3429 | 0.320 |
Why?
|
Semantics | 2 | 2012 | 601 | 0.310 |
Why?
|
Calcineurin | 2 | 2019 | 229 | 0.300 |
Why?
|
Database Management Systems | 1 | 2008 | 257 | 0.290 |
Why?
|
Proteomics | 5 | 2024 | 3849 | 0.280 |
Why?
|
Information Storage and Retrieval | 2 | 2012 | 819 | 0.280 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2017 | 140 | 0.260 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2024 | 1469 | 0.250 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12690 | 0.230 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9420 | 0.220 |
Why?
|
Pick Disease of the Brain | 1 | 2024 | 42 | 0.220 |
Why?
|
Administration, Intravesical | 1 | 2023 | 92 | 0.220 |
Why?
|
Dimethyl Sulfoxide | 1 | 2024 | 251 | 0.210 |
Why?
|
Cryoprotective Agents | 1 | 2024 | 128 | 0.210 |
Why?
|
Humans | 49 | 2024 | 761504 | 0.190 |
Why?
|
Receptors, GABA | 2 | 2022 | 313 | 0.190 |
Why?
|
Aged | 16 | 2024 | 169289 | 0.180 |
Why?
|
Cyclohexylamines | 1 | 2020 | 21 | 0.180 |
Why?
|
Probability | 2 | 2023 | 2477 | 0.180 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2020 | 87 | 0.180 |
Why?
|
Mice | 16 | 2024 | 81525 | 0.180 |
Why?
|
BCG Vaccine | 1 | 2023 | 369 | 0.180 |
Why?
|
Information Dissemination | 1 | 2008 | 1126 | 0.170 |
Why?
|
Software | 2 | 2011 | 4434 | 0.170 |
Why?
|
Phenylenediamines | 1 | 2020 | 88 | 0.170 |
Why?
|
Alleles | 2 | 2021 | 6863 | 0.170 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3396 | 0.160 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2019 | 87 | 0.160 |
Why?
|
Apolipoprotein E4 | 1 | 2023 | 708 | 0.160 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2020 | 553 | 0.160 |
Why?
|
Carbolines | 1 | 2020 | 296 | 0.150 |
Why?
|
Lewy Body Disease | 1 | 2020 | 252 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17904 | 0.150 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 256 | 0.150 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2019 | 158 | 0.150 |
Why?
|
Animals | 22 | 2024 | 168459 | 0.150 |
Why?
|
Mitochondrial Membranes | 1 | 2019 | 176 | 0.150 |
Why?
|
Computational Biology | 4 | 2024 | 3518 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 1036 | 0.150 |
Why?
|
Aging | 4 | 2021 | 8708 | 0.140 |
Why?
|
Parkinson Disease | 1 | 2011 | 2877 | 0.140 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 454 | 0.140 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 182 | 0.140 |
Why?
|
Neuropeptides | 1 | 2023 | 944 | 0.140 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58976 | 0.140 |
Why?
|
RNA, Messenger | 4 | 2024 | 12795 | 0.140 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.140 |
Why?
|
Neuroglia | 2 | 2019 | 956 | 0.140 |
Why?
|
Antimalarials | 1 | 2023 | 907 | 0.140 |
Why?
|
Biomedical Research | 3 | 2024 | 3429 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 577 | 0.130 |
Why?
|
Administration, Intranasal | 1 | 2018 | 477 | 0.130 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18252 | 0.130 |
Why?
|
Down Syndrome | 1 | 2024 | 901 | 0.130 |
Why?
|
Muscular Dystrophies | 1 | 2018 | 390 | 0.130 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2018 | 278 | 0.130 |
Why?
|
Cognition | 3 | 2023 | 6990 | 0.130 |
Why?
|
Membrane Transport Proteins | 2 | 2019 | 1035 | 0.130 |
Why?
|
Male | 21 | 2024 | 360804 | 0.130 |
Why?
|
Genome, Fungal | 1 | 1997 | 203 | 0.130 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2023 | 895 | 0.130 |
Why?
|
Homozygote | 1 | 2020 | 1776 | 0.120 |
Why?
|
Databases, Factual | 2 | 2008 | 7967 | 0.120 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 727 | 0.120 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 1320 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 733 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1659 | 0.120 |
Why?
|
Synapses | 2 | 2021 | 1769 | 0.110 |
Why?
|
Cerebrovascular Disorders | 1 | 2021 | 1474 | 0.110 |
Why?
|
Random Allocation | 1 | 2018 | 2395 | 0.110 |
Why?
|
Natural Language Processing | 1 | 2022 | 1162 | 0.110 |
Why?
|
Presenilin-1 | 1 | 2017 | 660 | 0.110 |
Why?
|
Cells, Cultured | 5 | 2024 | 18965 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1093 | 0.110 |
Why?
|
Female | 16 | 2024 | 392644 | 0.110 |
Why?
|
Mitochondria | 3 | 2024 | 3624 | 0.110 |
Why?
|
Europe | 1 | 2020 | 3422 | 0.100 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1027 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 36426 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15842 | 0.100 |
Why?
|
Histones | 2 | 2013 | 2580 | 0.100 |
Why?
|
tau Proteins | 2 | 2024 | 2095 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2735 | 0.100 |
Why?
|
Memory, Short-Term | 1 | 2018 | 982 | 0.100 |
Why?
|
Delirium | 1 | 2023 | 1668 | 0.090 |
Why?
|
Ubiquitins | 1 | 2013 | 366 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2049 | 0.090 |
Why?
|
Inflammation | 3 | 2020 | 10773 | 0.090 |
Why?
|
Survival Analysis | 1 | 2023 | 10090 | 0.090 |
Why?
|
Mice, Transgenic | 6 | 2019 | 9539 | 0.090 |
Why?
|
Medical Informatics Applications | 1 | 2012 | 178 | 0.090 |
Why?
|
Memory | 1 | 2020 | 2188 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6534 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2024 | 12341 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2023 | 5294 | 0.080 |
Why?
|
Huntington Disease | 2 | 2013 | 1144 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12148 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2053 | 0.080 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14605 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12463 | 0.080 |
Why?
|
Cohort Studies | 2 | 2023 | 41487 | 0.080 |
Why?
|
Axons | 1 | 2016 | 1674 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3617 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1006 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2957 | 0.070 |
Why?
|
Middle Aged | 8 | 2024 | 220895 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2018 | 2727 | 0.070 |
Why?
|
Proteins | 2 | 2000 | 6032 | 0.070 |
Why?
|
Calcium | 1 | 2020 | 5722 | 0.070 |
Why?
|
Cytokines | 2 | 2018 | 7396 | 0.070 |
Why?
|
Oxidation-Reduction | 2 | 2024 | 2231 | 0.070 |
Why?
|
Corpus Striatum | 1 | 2012 | 1235 | 0.070 |
Why?
|
Saccharomyces cerevisiae | 1 | 1997 | 2688 | 0.060 |
Why?
|
Algorithms | 3 | 2023 | 14031 | 0.060 |
Why?
|
Blood Pressure | 1 | 2021 | 8481 | 0.060 |
Why?
|
Electroencephalography | 1 | 2021 | 6225 | 0.060 |
Why?
|
Genotype | 1 | 2020 | 12990 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2011 | 1400 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2919 | 0.060 |
Why?
|
United States | 3 | 2024 | 72334 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4811 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16591 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3613 | 0.060 |
Why?
|
Genome | 1 | 2012 | 1740 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20098 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6770 | 0.060 |
Why?
|
Ethyl Ethers | 1 | 2023 | 20 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 22169 | 0.060 |
Why?
|
Stathmin | 1 | 2024 | 70 | 0.060 |
Why?
|
Caenorhabditis elegans | 3 | 2023 | 1456 | 0.060 |
Why?
|
Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.060 |
Why?
|
Longevity | 2 | 2023 | 1065 | 0.060 |
Why?
|
Ethers | 1 | 2023 | 73 | 0.050 |
Why?
|
Chromogranin A | 1 | 2023 | 49 | 0.050 |
Why?
|
Solitary Nucleus | 1 | 2023 | 54 | 0.050 |
Why?
|
Genetic Loci | 1 | 2012 | 2632 | 0.050 |
Why?
|
Chromogranins | 1 | 2023 | 161 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3979 | 0.050 |
Why?
|
Entorhinal Cortex | 1 | 2023 | 287 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2024 | 3113 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2022 | 219 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2022 | 233 | 0.040 |
Why?
|
Gliosis | 1 | 2021 | 245 | 0.040 |
Why?
|
Oleic Acid | 1 | 2020 | 92 | 0.040 |
Why?
|
Apoptosis | 1 | 2016 | 9486 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 793 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2023 | 695 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2024 | 1572 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2023 | 624 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14414 | 0.040 |
Why?
|
Models, Molecular | 2 | 2000 | 5439 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2020 | 271 | 0.040 |
Why?
|
Aldehydes | 1 | 2020 | 170 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15936 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23445 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 823 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2020 | 295 | 0.040 |
Why?
|
Presenilins | 1 | 2019 | 53 | 0.040 |
Why?
|
RNA Splicing | 1 | 2024 | 918 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
Hospitals, General | 1 | 2023 | 798 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2023 | 3548 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 697 | 0.040 |
Why?
|
Myotonic Dystrophy | 1 | 2018 | 78 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2024 | 879 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 754 | 0.040 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 305 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 732 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1657 | 0.040 |
Why?
|
Methanococcus | 1 | 1997 | 10 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 983 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11076 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3745 | 0.040 |
Why?
|
Medical Records | 1 | 2022 | 1408 | 0.040 |
Why?
|
Permeability | 1 | 2019 | 723 | 0.030 |
Why?
|
Glycolysis | 1 | 2021 | 835 | 0.030 |
Why?
|
Cytosol | 1 | 2020 | 888 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1638 | 0.030 |
Why?
|
Independent Living | 1 | 2021 | 579 | 0.030 |
Why?
|
Caloric Restriction | 1 | 2019 | 299 | 0.030 |
Why?
|
HIV Infections | 1 | 2023 | 17351 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 2018 | 389 | 0.030 |
Why?
|
Serotonin | 1 | 2021 | 1041 | 0.030 |
Why?
|
Suppression, Genetic | 1 | 2016 | 190 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7581 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1745 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2021 | 852 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2016 | 130 | 0.030 |
Why?
|
Antioxidants | 1 | 2024 | 1668 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2024 | 2909 | 0.030 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2018 | 267 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1008 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 857 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2000 | 2180 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6485 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14666 | 0.030 |
Why?
|
Cell Survival | 1 | 2024 | 5791 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3778 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2192 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 594 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 2224 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3322 | 0.030 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2019 | 1111 | 0.030 |
Why?
|
Open Reading Frames | 1 | 1997 | 815 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13446 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3579 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3792 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1597 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2449 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1997 | 910 | 0.030 |
Why?
|
Blotting, Western | 1 | 2020 | 5035 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2018 | 1756 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2019 | 1023 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3341 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1606 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2019 | 874 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15266 | 0.030 |
Why?
|
Necrosis | 1 | 2016 | 1611 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11903 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1326 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7045 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2023 | 5112 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 855 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8320 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4278 | 0.020 |
Why?
|
Acetylation | 1 | 2012 | 1055 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29625 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2018 | 3395 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3575 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80636 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2639 | 0.020 |
Why?
|
Spinal Cord | 1 | 2016 | 1818 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2723 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6240 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 774 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54425 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1997 | 2691 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4398 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9606 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1509 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 9000 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3766 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4575 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2012 | 1742 | 0.020 |
Why?
|
MicroRNAs | 1 | 2021 | 3816 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74206 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3448 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16981 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10723 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15631 | 0.010 |
Why?
|
Retinoid X Receptors | 1 | 2000 | 91 | 0.010 |
Why?
|
Receptors, Retinoic Acid | 1 | 2000 | 224 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39967 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7594 | 0.010 |
Why?
|
Dimerization | 1 | 2000 | 891 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2000 | 931 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17635 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64680 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30052 | 0.010 |
Why?
|
Binding Sites | 1 | 2000 | 6055 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2000 | 2986 | 0.010 |
Why?
|
Adult | 1 | 2021 | 221177 | 0.000 |
Why?
|
Transcription Factors | 1 | 2000 | 12128 | 0.000 |
Why?
|